The exosome diagnostic and therapeutic market is projected to grow at a CAGR of 9.1% from 2024 to 2034. Market valuation will increase from USD 88.56 million in 2024 to USD 211.6 million by 2034.

Highlights:,Drive-by VCs invest in multiple startups but with minimal involvement.,They focus on quick exits rather than long-term engagement.,Their strategy contrasts with traditional venture capital ...

The "Stem Cell Manufacturing Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The stem cell manufacturing market is forecasted to grow by USD 6.43 billion during 2023-2028, ...

GMP Protein (E. Coli) Contract Manufacturing Market Set To Witness Significant Growth By 2025-2032: Abcam Plc, Genscript GMP Protein (E. coli) Contract manufacturing market 2025 GMP Protein (E. coli) ...

The global cell therapy manufacturing industry is poised for rapid growth, with a projected valuation of USD 4,134.48 million ...

According to the final weekly tracker poll by Techne UK, the Tories have gone up a point to 26 per cent in the last week putting them a mere 1 per cent behind Labour who remain the same on 27 per ...

The shares have sprung back to life thanks to China’s new stimulus programs—and Alibaba’s AI ventures. They stand to gain as much as 48%.

The global organoids market was estimated at US$ 59 million in 2023 and is projected to reach about US$ 381.7 million by 2034, expanding at a compound annual growth rate (CAGR) of 18.5% from 2024 to ...

Bio-Techne Corp. TECH has launched a highly sensitive ESR1 mutation monitoring assay through its Asuragen brand. ESR1 gene mutations are known to be linked to hormone receptor-positive (HR+ ...